AKT1 and gastric cancer: COE reduced the expression levels of Bcl-2, Bcl-xL, and the PI3K/Akt/mTOR/p70s6k signaling pathway proteins, while simultaneously enhancing the levels of Bax and caspase proteins in gastric cancer cells (Wang et al., 2017b).